The Brief
What Tempus AI Next does
Tempus Next uses AI to recommend the most effective next treatment for cancer patients based on genomic data, treatment history, and real-world evidence from similar patients in the Tempus database.
Builder’s Brief
Tempus AI Next is a healthcare tool on Falcoscan. AI-powered next best therapy recommendations for oncology. Falcoscan rates Tempus AI Next with an Opportunity score of 88/100, a Saturation score of 8/100, and a Wrapper-risk score of 6/100. Market signal: hot. Tempus AI Next is founded in 2023, currently at Series_a stage. Pricing: Paid. Rating 4.7/5 across 63 tracked views.